「lt」の検索結果
399件：386～390件目を表示
-
l Trials use a novel compound discovered by Mochida and licensed to Senju Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter: Senju) and Mochida Pha...
https://www.senju.co.jp/sites/default/files/content_news/2023-03/ENG_20230322.pdf -
General Announcement: April 23, 2024 Senju Pharmaceutical Co., Ltd. Launch and Distribution of “MIEr for NAVIS” Senju Pharmaceutical Co., Ltd., hereby announces the commercial launch and distribution ...
https://www.senju.co.jp/sites/default/files/content_news/2024-04/ENG_20240423_0.pdf -
論文投稿実績 | 研究開発活動 | 千寿製薬株式会社
addition Shuya Masuda 1,2, Shiho Yano 1, Tomohisa Tadokoro 1, Hiroko Otake 1, Noriaki Nagai 1 1 Faculty of Pharmacy, Kindai University 2 Pharmaceutical Research Laboratories, Senju Pharmaceutical Co.,...
https://www.senju.co.jp/rd/thesis/ -
l Trials use a novel compound discovered by Mochida and licensed to Senju Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter: Senju) and Mochida Pha...
https://www.senju.co.jp/sites/default/files/content_news/2023-03/ENG_20230322_0.pdf -
General Announcement: April 23, 2024 Senju Pharmaceutical Co., Ltd. Launch and Distribution of “MIEr for NAVIS” Senju Pharmaceutical Co., Ltd., hereby announces the commercial launch and distribution ...
https://www.senju.co.jp/sites/default/files/content_news/2024-04/ENG_20240423.pdf